About Us
My story
I was diagnosed with Crohn’s disease in 1998, and by 2000, my condition worsened, leading to multiple hospitalizations. Seeing young patients, some as young as 13-15 years old, opt for colon removal and stomas just to escape the pain deeply impacted me. I knew I had to make a difference.
In 2009, I began researching microbiology, biotechnology, and intestinal diseases and found that patients with Inflammatory Bowel Disease (IBD) have a disrupted gut microbiota, harboring disease-causing bacteria—similar to patterns seen in other chronic illnesses
Hengameh Chloe Lauridsen
M.Sc., Ph.D., Senior Researcher Scientist, 1Health Gut Inn Balance APS
Why we initiated the research
Restoring Intestinal Microbiota Balance
When I initiated my research in microbiology / biotechnology and intestinal diseases in 2008 and I could see the intestinal microbiota of patients with Inflammatory Bowel Disease is abnormal with disease causing bacteria. I realize that by transplanting the intestinal environment from a healthy patient to disease, we enable promoting remission in these patients.
I have a PhD in Microbiology and Inflammatory bowel disease, and a master degree in Chemistry and Biotechnology. Since 2009 I have perform research in the field at Statens Serum Institut, Roskilde University and now I am at Hvidovre Hospital, in collaboration with GIB, to improve patient therapy and quality of life.
Now I want to help all the world by automatic my production method, enabling all the hospital treating their patients effectively and cheaper.
Read the article
Researchers from Hvidovre Hospital are now starting to test whether capsules containing feces can help healthy carriers of, among other things, the multi-resistant bacteria CPO in the intestine. CPO has most recently been found in the antibiotic preparation Dicillin.